SCHEMBL7974309

SCHEMBL7974309

Cc1cccc(Cn2cnc3nc(-c4ccccc4F)nc(O)c32)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 4/20 0.42
HPGD P15428 4/20 0.42
MAPK14 Q16539 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MET P08581 1/20 0.39
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
ALOX15 P16050 1/20 0.35
MMP13 P45452 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988454 0.89 MAPK14 (0.41) CYP11B1CYP11B2MAPK14METGAA
SCHEMBL7974060 0.88 SMN1; SMN2 (0.41) CYP11B1CYP11B2ALDH1A1HPGDMAPK14
SCHEMBL7974646 0.88 MAPK14 (0.47) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7984878 0.88 MAPK14 (0.42) MAPK14SMN1; SMN2METLMNAHTT
SCHEMBL7985870 0.87 GAA (0.50) ALDH1A1TSHRHPGDMAPK14GAA
SCHEMBL7974268 0.85 CYP11B1 (0.48) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7991788 0.84 CYP11B1 (0.46) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7988567 0.84 HPGD (0.44) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7988184 0.84 MET (0.42) CYP11B1CYP11B2ALDH1A1TSHRHPGD
SCHEMBL7988958 0.83 ALDH1A1 (0.42) CYP11B1CYP11B2ALDH1A1TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed